Creso Pharma Limited COPHF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • AU • USD

SharesGrow Score

18/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Creso Pharma Limited (COPHF) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 17/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

18/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

22/100

→ Income

成长

58/100

→ Income

✗

收入

10/100

→ Income

估值概览 — COPHF

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$0.00

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2016	$-0.14	$8.02K	$-4.58M	-57145.8%
2017	$-0.18	$243.8K	$-15.08M	-6183.8%
2018	$-0.15	$578.22K	$-16.76M	-2897.9%
2019	$-0.12	$3.63M	$-17.05M	-470.3%
2020	$-0.10	$2.45M	$-37.58M	-1535.2%
2021	$-0.03	$6.22M	$-31.77M	-510.8%
2022	$-0.02	$8.69M	$-32.78M	-377.3%
2023	$0.00	$18.92M	$-52.45M	-277.2%